Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced Apoptosis

1 Apr 2004

Abstract excerpt

Cancer cells are more susceptible to chemotherapeutic agent-induced apoptosis than their normal counterparts. Although it has been demonstrated that the increased sensitivity results from deregulation of oncoproteins during cancer development (Evan, G. I., and Vousden, K. H. (2001) Nature 411, 342-348; Green, D. R., and Evan, G. I. (2002) Cancer Cell 1, 19-30), little is known about the signaling pathways leading...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell death mechanisms and regulation
Share to Heat shock proteins research
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 14766752
DOI: 10.1074/jbc.m313816200

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

RKIP Sensitizes Prostate and Breast Cancer Cells to Drug-induced ApoptosisPMID 14766752Read ↗

The biological complexity of RKIP signaling in human cancersSemantic proximity Read ↗

Survey of Raf Kinase Inhibitor Protein (RKIP) in Multiple Cancer TypesSemantic proximity Read ↗

A New Model for Raf Kinase Inhibitory Protein Induced Chemotherapeutic ResistanceSemantic proximity Read ↗

Cancer resistance via the downregulation of the tumor suppressors RKIP and PTEN expressions: therapeutic implicationsSemantic proximity Read ↗

RIPK4 Downregulation Reduces ABCG2 Expression, Increasing BRAF-Mutated Melanoma Cell Susceptibility to Cisplatin- and Doxorubicin-Induced Apoptosis.Semantic proximity Read ↗

Apoptosis evasion: The role of survival pathways in prostate cancer progression and therapeutic resistanceSemantic proximity Read ↗

Rho GDP dissociation inhibitor protects cancer cells against drug-induced apoptosis.Semantic proximity Read ↗

RNA silencing of checkpoint regulators sensitizes p53-defective prostate cancer cells to chemotherapy while sparing normal cells.Semantic proximity Read ↗

Ran is a potential therapeutic target for cancer cells with molecular changes associated with activation of the PI3K/Akt/mTORC1 and Ras/MEK/ERK pathways.Semantic proximity Read ↗

The Role of RKIP in the Regulation of EMT in the Tumor MicroenvironmentSemantic proximity Read ↗

Raf kinase inhibitory protein regulates Raf-1 but not B-Raf kinase activation.Semantic proximity Read ↗

RKIP inhibits the malignant phenotypes of gastric cancer cells.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.